Document is current
Any future updates will be listed below
-
Authors
Avanceña, Anton L. V. https://orcid.org/0000-0002-4903-870X
Okoye, Godwin
Yokananth, Rishit
Norwood, Aliza
Schnarrs, Phillip W.
Barner, Jamie C.
-
Funding
Funding for this research was provided by:
National Center for Advancing Translational Sciences (K12TR004529)
Dell Medical School, University of Texas at Austin
Texas Institute for Sexual and Gender Minority Health Research
- License Information
-
More Information
Article History
Received: 18 June 2025
Accepted: 15 December 2025
First Online: 27 January 2026
Declarations
:
: We used de-identified healthcare claims and administrative data in this study. This study was exempt from full ethics review by The University of Texas Institutional Review Board (STUDY00006393).
: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funders.
: Drs. Schnarrs and Norwood have received funding from Merck Sharp & Dohme Corp. Investigator Studies Program to study preferences for longer-acting preexposure prophylaxis among gay, bisexual, and other men who have sex with men (MISP 10080) and transgender and gender-expansive populations (MISP 60761).
